Prophylaxis Roles of IL-2 Treatment on GVHD After Transplantation

Summary

The effects of haploidentical rhG-CSF-mobilized unmanipulated blood and marrow transplantation (HBMT) on hematological malignancies are well established.The aim of this prospective cohort trial is to determine if acute graft-versus-host disease (aGVHD) could be decreased with IL2 therapy post HBMT.

Timeline

Start

2015-03

Primary completion

2021-06

Completion

2021-12

Drugs

Indications